ACE and Hyperkalemia: Another retrospective cohort study indicated that patients treated with ARBs alone had a poorer renal prognosis [HR (hazard ratio) 1.31] and a higher risk of hyperkalemia (HR 1.17) compared to those treated with Angiotensin converting enzyme inhibitors (ACEIs) alone.